"TearScience has intentionally kept a low profile - it doesn't even have a Web site <it does now, see below> - while it focused on developing its devices. The company has applied for more than 40 patents to date."
"It was best to stay under the radar until we had all our patents filed," said Brian Regan, vice president of marketing and market development.
Read more: http://www.newsobserver.com/2010/05/...#ixzz0n3s6Z25I
"The $44.5 million raised in TearScience’s series C round is the largest medical technology venture capital funding in the Southeast this year and the largest in North Carolina since TransEnterix raised $55 million in a series B round of funding in October. To date, TearScience now has raised a total of $61 million in venture financing."
http://triangle.bizjournals.com/tria...3/daily38.html
http://www.tearscience.com/press-releases/
"It was best to stay under the radar until we had all our patents filed," said Brian Regan, vice president of marketing and market development.
Read more: http://www.newsobserver.com/2010/05/...#ixzz0n3s6Z25I
"The $44.5 million raised in TearScience’s series C round is the largest medical technology venture capital funding in the Southeast this year and the largest in North Carolina since TransEnterix raised $55 million in a series B round of funding in October. To date, TearScience now has raised a total of $61 million in venture financing."
http://triangle.bizjournals.com/tria...3/daily38.html
http://www.tearscience.com/press-releases/
Comment